Deep Track Capital, LP - Sep 30, 2025 SCHEDULE 13G/A Report for INOVIO PHARMACEUTICALS, INC. Common Stock, $0.001 par value (INO)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
INOVIO PHARMACEUTICALS, INC. Common Stock, $0.001 par value
Symbol
INO
Shares outstanding
54.6M shares
Disclosed Ownership
1.31M shares
Ownership
2.41%
Form type
SCHEDULE 13G/A
Date filed
11/14/2025, 08:15 AM
Date of event
Sep 30, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 2.41% 1.31M 0 1.31M David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 2.41% 1.31M 0 1.31M David Kroin David Kroin, Director
David Kroin 2.41% 1.31M 0 1.31M David Kroin David Kroin